The United Kingdom is witnessing a significant surge in interest surrounding entheogenic substances. Beyond the well-established use of psilocybin and LSD, researchers and adventurers are increasingly focused on less-charted frontiers, particularly copyright and the budding cannabinoid, CBG. The